Participate in a Study

Clinical Research Services

Is research for you? Millions of people volunteer for research studies every year. There are many reasons that people volunteer. For some it is a way to access new potential treatments for their particular disease or condition. Others appreciate the close medical attention they receive while taking part in the study. People also get involved to help others through the advancement of medical knowledge.

Download the Clinical Research Services Brochure:
Volunteer for CRS

Advancing the Future of Medicine Through Research:
To learn more about clinical research studies watch this video.

Cardiology
A research study of an investigational drug for people who have suffered from myocardial infarction (heart attack) and are waiting to potentially undergo a procedure called percutaneous coronary intervention (PCI).

Internal Medicine
A study of an investigational oral (taken by mouth) drug for treatment for type 2 diabetes.

A study of an investigational medication for the treatment of the flu.

Men’s Health Studies
A study to determine the safety and effectiveness of an investigational drug in the treatment of BPH (enlarged prostate) in men.

Oncology
A research study of an investigational drug for patients with metastatic pancreatic cancer. The study is trying to determine if the Investigational Drug, combined with gemcitabine, results in a better outcome for patients than treatment with gemcitabine alone. Gemcitabine is approved by the United States Food and Drug Administration for the treatment of metastatic pancreatic cancer.

Rheumatology
A study to test the ability of etanercept (also called Enbrel®) to bring about control of rheumatoid arthritis in patients with moderately active rheumatoid arthritis who are already taking at least one “disease-modifying anti-rheumatic drug” (also called a DMARD; DMARDs are drugs like methotrexate or azathioprine).

Women’s Health Studies
A study of an investigational drug for pregnant women who have previously had a preterm birth (when a baby is born before 37 weeks of pregnancy ) to determine if the investigational drug will safely reduce the rate of early delivery.